Skip Navigation

Cardiovascular Research 2005 67(4):723-735; doi:10.1016/j.cardiores.2005.04.008
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Guo, Z.
Right arrow Articles by Gong, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guo, Z.
Right arrow Articles by Gong, M. C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2005, European Society of Cardiology

COX-2 Up-regulation and vascular smooth muscle contractile hyperreactivity in spontaneous diabetic db/db mice

Zhenheng Guoa, Wen Sua, Shannon Allena, Huan Panga, Alan Daughertya,b, Eric Smarta,c and Ming C. Gonga,*

aDepartment of Physiology, University of Kentucky, 509 Wethington Building, 900 South Limestone, Lexington, KY 40536, USA
bInternal Medicine, University of Kentucky, Lexington, KY 40536, USA
cPediatrics, University of Kentucky, Lexington, KY 40536, USA

* Corresponding author. Tel.: +1 859 323 4933x81361; fax: +1 859 257 3646. Email address: mcgong2{at}uky.edu

Objective: Abnormalities in vascular constriction and dilatation are associated with early diabetes and contribute to diabetic vascular complications. However, mechanisms underlying such vascular dysfunction remain to be fully elucidated. The current study tests the role of cyclooxygenase-2 (COX-2) in diabetic vascular smooth muscle dysfunction.

Methods: Small mesenteric artery and aorta are isolated from type 2 diabetic db/db and control mice. Isometric contractions in response to serotonin, angiotensin II, phenylephrine and high potassium are determined in small spiral mesenteric arterial or aortic strips. COX-2 mRNA and protein levels are analyzed by using DNA microarray, real-time PCR and immunoblot.

Results: Contractions induced by serotonin, angiotensin II, phenylephrine and high potassium are significantly higher in endothelium-denuded smooth muscle strips isolated from db/db mice than in those isolated from control mice. The contractile hyperreactivity is observed in aortic and third-order branch small mesenteric arterial smooth muscle strips. DNA microarray, real-time PCR and immunoblot analysis show that compared with control mice, COX-2 mRNA and protein are significantly increased in db/db mice aortic smooth muscle. The COX-2 up-regulation is temporally associated with the development of diabetes mellitus and vascular smooth muscle contractile hyperreactivity. Inhibition of COX-2 with NS-398 or SC-58125 partially–but significantly–alleviates agonist-induced but not potassium-induced contractile hyperreactivity. In addition, serum isolated from db/db mice induces COX-2 expression and increases thromboxane A2 production in primary cultured vascular smooth muscle cells (VSMC). SQ-29548, a TP receptor antagonist, diminished the db/db mice vascular smooth muscle contractile hyperreactivity.

Conclusions: COX-2 is up-regulated and contributes at least in part to the vascular smooth muscle contractile hyperreactivity in db/db mice.

KEYWORDS Vascular smooth muscle; Contraction; Type 2 Diabetes; Cyclooxygenase-2


Time for primary review 21 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
I. Rutkai, A. Feher, N. Erdei, D. Henrion, Z. Papp, I. Edes, A. Koller, G. Kaley, and Z. Bagi
Activation of prostaglandin E2 EP1 receptor increases arteriolar tone and blood pressure in mice with type 2 diabetes
Cardiovasc Res, July 1, 2009; 83(1): 148 - 154.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
D. Senador, K. Kanakamedala, M. C. Irigoyen, M. Morris, and K. M. Elased
Cardiovascular and autonomic phenotype of db/db diabetic mice
Exp Physiol, June 1, 2009; 94(6): 648 - 658.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. L. Park, L. Shu, and J. A. Shayman
Differential involvement of COX1 and COX2 in the vasculopathy associated with the {alpha}-galactosidase A-knockout mouse
Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H1133 - H1140.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Nacci, M. Tarquinio, L. De Benedictis, A. Mauro, A. Zigrino, M. R. Carratu, M. J. Quon, and M. Montagnani
Endothelial Dysfunction in Mice with Streptozotocin-induced Type 1 Diabetes Is Opposed by Compensatory Overexpression of Cyclooxygenase-2 in the Vasculature
Endocrinology, February 1, 2009; 150(2): 849 - 861.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. P. Kellogg, K. Converso, T. Wiggin, M. Stevens, and R. Pop-Busui
Effects of cyclooxygenase-2 gene inactivation on cardiac autonomic and left ventricular function in experimental diabetes
Am J Physiol Heart Circ Physiol, February 1, 2009; 296(2): H453 - H461.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. Su, Z. Guo, D. C. Randall, L. Cassis, D. R. Brown, and M. C. Gong
Hypertension and disrupted blood pressure circadian rhythm in Type 2 diabetic db/db mice
Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1634 - H1641.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.